IFPMA Data Ethics Principles
These Data Ethics Principles are intended to help the pharmaceutical industry use data responsibly and sustainably, in alignment with the IFPMA Ethos of care, fairness, respect, and honesty.
- Ethical data use is critical to innovation, advancing scientific and medical understanding, ensuring patient safety, and improving healthcare for the benefit of individual patients and broader society.
- Ethical data use helps build a culture of trust with our stakeholders. Conversely, unethical data use can harm individuals and society, and damage that trust. As stated in the IFPMA Code of Practice, “Patient trust is the lifeblood of our industry: we must take every opportunity to earn, sustain and grow that trust.” This includes how we handle and use data.
IFPMA Data Ethics Principles Webinar Video (June 2021):
Related news and resources
Enhanced collaboration between anti-doping agency and big pharma bolsters support for clean sport among athletes
On 3 April 2024 in Athens, the International Federationof Pharmaceutical Manufacturers and Associations (IFPMA) and the World Anti-Doping Agency (WADA) signed a joint letter of intent.
Read moreOur Ethos in Action – Decision-Making Framework Toolkit
IFPMA has developed a Five-Phase Decision-Making Framework, grounded in the IFPMA Ethos or value system, to help companies make decisions that balance business objectives and ethical considerations to meet patient needs and the expectations of the medical community, regulators, and society.
Read more
IFPMA and industry leaders applaud 10 years of collective action on ethics and business integrity in APEC region
Washington, D.C. and Geneva, 26 September 2023: This week, IFPMA joins hundreds of stakeholders from across economies in the Asia-Pacific at the APEC Business Ethics for SMEs Forum to recognize and applaud progress made by the initiative in the past decade to advance business ethics in the medical device and biopharmaceutical sectors in the region....
Read more